Skip to Content


Gelovani Joins M. D. Anderson to Lead Experimental Diagnostic Imaging

Gelovani Joins M. D. Anderson to Lead Experimental Diagnostic Imaging
M. D. Anderson News Release, 08/07/03

Juri G. Gelovani, M.D., has joined The University of Texas M. D. Anderson Cancer Center as professor and chair of the Department of Experimental Diagnostic Imaging in the Division of Radiation Oncology.

Before joining the faculty at M. D. Anderson, Gelovani served as the head of the molecular-genetic and cellular imaging section in the Department of Radiology at Memorial Sloan-Kettering Cancer Center.

Molecular imaging combines new molecular agents with traditional imaging tools to create more targeted therapies with the objective to simultaneously find, diagnose and treat disease. Gelovani’s research is focused on developing new approaches to molecular imaging that would help detect cancer at an earlier stage and enable care teams to assess the extent of the disease sooner – making a significant impact on the diagnosis, therapy and management of cancer.

Gelovani has developed and introduced into clinical settings several molecular imaging tools and applications, including a radiotracer for imaging DNA synthesis during the growth and spread of brain tumors. He also developed and validated the original methodology for the HSV1-tk marker gene using radio-labeled Fialuridine (FIAU) and its analogues for non-invasive monitoring of novel anti-cancer gene therapies; a discovery that initiated a new interdisciplinary field in biology and medicine.

“I am dedicated to providing my patients with the most compassionate and individualized care possible,” says Gelovani. “Working with my colleagues at M. D. Anderson, I am confident, will enable me to continue discovering new approaches for detecting, assessing and treating cancer to improve patients’ lives.”

A native of the Republic of Georgia, Gelovani received his medical degree and doctorate in neurosurgery from Tartu University in Estonia and completed his fellowship in neuro-oncology at Memorial Sloan-Kettering. In 2001, he received the International Fellow Award from the Alexander von Humboldt Foundation.

A member of the editorial review boards for Molecular Imaging and Neoplasia, Gelovani also has served on advisory boards for the development of several molecular imaging programs and protocols. In addition to his memberships in the American Association for Cancer Research and the American Society for Gene Therapy, Gelovani is the co-founder of the European Society for Neuro-Oncology and the Society for Molecular Imaging, which awarded him a gold medal for his contributions to the field in 2002.


© 2015 The University of Texas MD Anderson Cancer Center